BIOA · BioAge Labs, Inc.

$9.52 +0.02 (+0.21%) At close · Sep 1

Russell 2000 member Rebalance outlook locked

Market Cap

$436.02M

45.90M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	Chief Executive Officer and President	$600,000	—	—	$1,941,390	$330,000	$15,200	$2,886,590
Paul Rubin	Chief Medical Officer	$520,200	—	—	$732,600	$208,080	$15,200	$1,476,080
Eric Morgen	Chief Operating Officer	$499,600	—	—	$732,600	$199,840	$15,200	$1,447,240

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	Chief Executive Officer and President	$520,994	—	—	$11,482,514	$208,398	$15,000	$12,226,906
Eric Morgen	Chief Operating Officer	$457,657	—	—	$1,832,510	$160,180	$15,000	$2,465,347
Paul Rubin	Chief Medical Officer	$488,139	—	—	$1,249,853	$170,849	$15,000	$1,923,841

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	Chief Executive Officer and President	$493,271	—	—	$626,169	$246,635	$14,400	$1,380,475
Eric Morgen	Chief Operating Officer	$435,686	—	—	$232,099	$190,613	$14,400	$872,798
Paul Rubin	Chief Medical Officer	$468,939	—	—	$148,262	$205,161	$14,400	$836,762

Key facts CIK 1709941 CUSIP 09077V100 13F (30d) 132 filings 131 filers Visit website Investor relations